Magellan Health Collaborating With Click Therapeutics To Develop Therapeutic Mobile Apps

Magellan Health announced that it will be collaborating with Click Therapeutics to obtain Food and Drug Administration (FDA) clearance for therapeutic apps. Through this collaboration, Magellan seeks to extend its efforts in providing broad-based, digital, and data-driven programs for primary care and specialty care provider organizations.

Together, the two organizations will take advantage of each other's resources in order to create mobile apps for consumers living with conditions such as addiction disorder, insomnia, depression, and anxiety. They will then apply for FDA clearance for these apps, citing valid scientific evidence for the safety and efficacy of such . . .